FDA
-
-
-
-
-
-
-
Neothetics (NEOT) Receives Issuance of Eighth U.S. Patent Related to LIPO-202 Lead Clinical Asset
-
-
-
-
-
-
-
Neothetics (NEOT) Phase 2 Proof of Concept Trial for LIPO-202 Initiated for Double Chin
-
322,969 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

